Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).
about
No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs: a systematic literature review and meta-analysisTocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials.Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritisMethotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.Treatment with Biologicals in Rheumatoid Arthritis: An Overview.Treatment of rheumatoid arthritis with biological agents - as a typical and common immune-mediated inflammatory disease.Changes in serum interleukin-6 levels as possible predictor of efficacy of tocilizumab treatment in rheumatoid arthritis.Profile of tocilizumab and its potential in the treatment of giant cell arteritis.Effectiveness of golimumab for rheumatoid arthritis in patients with an inadequate response to tocilizumab.A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases.Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases
P2860
Q36300250-262346BE-8FDD-4B99-815B-5C5B8EF64E32Q37278384-C05A0435-2575-4860-A981-7137B942E82DQ37622219-FF170EF4-D975-4DCD-8C41-7A333AC9F7F4Q38939820-4A204C6F-163B-4892-859F-86C13E5CC0FAQ47132835-4B6DCECA-6441-4CB6-A6E4-8DF41C95299CQ47163453-72FF6447-3FE3-4D54-990B-5CE16B2CD84EQ48022107-EED4F625-90E0-4C7E-A949-3302C1CCF2F1Q49215677-EF2E6A23-C861-411B-A2F7-37CBE6DDDA3AQ51557013-27491E52-1F1F-4D68-975A-D868A7BBF949Q52675492-BAED1377-202E-4EC0-BB8C-1A409D2C9124Q58750029-B14AB74A-4767-4693-8863-CE87BA003143
P2860
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of adding tocilizum ...... rolled study (SURPRISE study).
@en
Comparison of adding tocilizum ...... rolled study (SURPRISE study).
@nl
type
label
Comparison of adding tocilizum ...... rolled study (SURPRISE study).
@en
Comparison of adding tocilizum ...... rolled study (SURPRISE study).
@nl
prefLabel
Comparison of adding tocilizum ...... rolled study (SURPRISE study).
@en
Comparison of adding tocilizum ...... rolled study (SURPRISE study).
@nl
P2093
P2860
P1476
Comparison of adding tocilizum ...... trolled study (SURPRISE study)
@en
P2093
Eiichi Tanaka
Hayato Nagasawa
Hidekata Yasuoka
Hisashi Yamanaka
Hitomi Kobayashi-Haraoka
Kazuhiko Yamamoto
Koichi Amano
Masayuki Inoo
Masayuki Miyata
Nobuyuki Miyasaka
P2860
P304
P356
10.1136/ANNRHEUMDIS-2015-208426
P407
P577
2016-01-05T00:00:00Z